Close

Analyst Ratings for Affimed Therapeutics (AFMD) [Neutrals]

AFMD Rating Summary

AFMD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AFMD
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $12.00 (+145.9%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 90%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/10/2022 Stifel
» Updated 4/1/2024
Bradley Canino Downgrade Hold
(Buy)
5.00
(1.00)
1.90
(4.88)
156.84% Details